Tissue-resident Immune Cell Subsets in aGVHD

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

NCT06208137 ·Status: RECRUITING ·Phase: NA

Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells

NCT02291770 ·Status: UNKNOWN ·Phase: PHASE3

MSC for Severe aGVHD

NCT03631589 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)

NCT06247150 ·Status: RECRUITING ·Phase: NA

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

NCT07150468 ·Status: COMPLETED

Role of aGVHD Biomarkers on aGVHD Risks

NCT04284904 ·Status: COMPLETED

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

NCT07235501 ·Status: NOT_YET_RECRUITING

oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort

NCT05170347 ·Status: RECRUITING

Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts

NCT00658073 ·Status: COMPLETED ·Phase: NA

Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation

NCT02659657 ·Status: UNKNOWN ·Phase: PHASE2

The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT

NCT06864598 ·Status: ENROLLING_BY_INVITATION

The Association of Microbiota Composition With cGVHD After Allo-HSCT

NCT05355675 ·Status: UNKNOWN

Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease

NCT05152160 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients

NCT07297303 ·Status: RECRUITING

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)

NCT02194868 ·Status: COMPLETED

MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD

NCT02241018 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation

NCT01530581 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

NCT00179049 ·Status: COMPLETED

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

NCT05866302 ·Status: RECRUITING

A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

NCT06949267 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease

NCT01754454 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT

NCT06143501 ·Status: RECRUITING

A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF

NCT00208949 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease

NCT01526850 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

NCT02563340 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2